Polo-like kinase 1–inhibitor co-complex structures via the surface-entropy reduction approach and a DARPin-assisted approach
Open Access
- 17 November 2025
- journal article
- Published by International Union of Crystallography (IUCr) in Acta Crystallographica Section D Structural Biology
- Vol. 81 (12) , 718-733
Abstract
Polo-like kinase 1 (PLK1) is a major regulator of cell division and has been pursued as a drug target for cancer therapy for a long time. Crystallization of the kinase domain has proven to be exceptionally challenging. Previously, we published a crystallization approach using a PLK1-specific designed ankyrin-repeat protein (DARPin) as a crystallization facilitator. Here, we report an alternative route: crystallization was successful after the introduction of a double mutation which reduced surface entropy and enabled the formation of a new crystal contact. This new PLK1 crystallization system was used to determine the first co-complex crystal structure of the Bayer thiazolidinone lead series, as well as crystal structures with representatives of two competitor inhibitor series. The molecular binding modes of these three inhibitors are analysed and discussed, and the surface-entropy reduction approach is compared with the surface modifications employed by us and others to enable the crystallization of PLK1.Keywords
Funding Information
- Fundação para a Ciência e a Tecnologia
This publication has 43 references indexed in Scilit:
- Discovery of IRAK4 Inhibitors BAY1834845 (Zabedosertib) and BAY1830839Journal of Medicinal Chemistry, 2024
- Treating Cancer by Spindle Assembly Checkpoint Abrogation: Discovery of Two Clinical Candidates, BAY 1161909 and BAY 1217389, Targeting MPS1 KinaseJournal of Medicinal Chemistry, 2020
- Discovery of BAY-985, a Highly Selective TBK1/IKKε InhibitorJournal of Medicinal Chemistry, 2019
- Targeting Polo-Like Kinases: A Promising Therapeutic Approach for Cancer TreatmentTranslational Oncology, 2015
- The Small-Molecule Inhibitor BI 2536 Reveals Novel Insights into Mitotic Roles of Polo-like Kinase 1Current Biology, 2007
- BI 2536, a Potent and Selective Inhibitor of Polo-like Kinase 1, Inhibits Tumor Growth In VivoCurrent Biology, 2007
- 5-(1H-Benzimidazol-1-yl)-3-alkoxy-2-thiophenecarbonitriles as potent, selective, inhibitors of IKK-ε kinaseBioorganic & Medicinal Chemistry Letters, 2006
- Rational Protein Crystallization by Mutational Surface EngineeringStructure, 2004
- More hydrogen bonds for the (structural) biologistTrends in Biochemical Sciences, 2001
- [20] Processing of X-ray diffraction data collected in oscillation mode1997